Related Experiment Videos

Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis

Irina V Budunova1, Dariusz Kowalczyk, Paloma Pérez

  • 1AMC Cancer Research Center, 1600 Pierce Street, Denver, CO 80214, USA.

Oncogene
|May 23, 2003
PubMed

Insights

Glucocorticoid receptor (GR) overexpression in skin suppresses tumor development by inhibiting epidermal proliferation and blocking NF-kappaB. This finding highlights GR

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Glucocorticoids inhibit epidermal proliferation and skin tumorigenesis.
  • Glucocorticoid receptor (GR) is a transcription factor mediating glucocorticoid effects.
  • Skin-targeted transgenic mice overexpressing GR (K5-GR) were generated.

Purpose of the Study:

  • To investigate the tumor-suppressive role of GR in skin.
  • To test if GR overexpression inhibits skin carcinogenesis.
  • To elucidate the molecular mechanisms underlying GR's tumor-suppressive effects.

Main Methods:

  • K5-GR transgenic mice were bred with Tg.AC transgenic mice (v-Ha-ras oncogene).
  • F1 offspring were subjected to TPA-induced skin carcinogenesis.
  • Tumor development, size, keratinocyte proliferation, apoptosis, differentiation, and NF-kappaB activity were analyzed.

Main Results:

  • GR overexpression dramatically inhibited skin tumor development.
  • Papilloma incidence and size were significantly reduced in K5-GR/ras+ mice compared to wild-type littermates.
  • GR overexpression decreased keratinocyte proliferation, increased apoptosis and differentiation, and blocked NF-kappaB signaling.

Conclusions:

  • GR acts as a tumor suppressor in the skin.
  • GR's tumor-suppressive effect is mediated, in part, by the blockage of NF-kappaB signaling.
  • Targeting GR may offer a therapeutic strategy for skin cancer prevention and treatment.

Related Concept Videos